Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...

In April 2025 , Northstrive Biosciences announced it received preliminary feedback from the FDA on its planned Type B pre-IND ...

Novo Nordisk is a sector leader in the fast-growing GLP-1 market, boasting strong fundamentals. Click here to read why I rate ...

Viking Therapeutics, Inc.'s VK2735 trial results disappointed, yet long-term potential in the obesity market makes the stock ...

In recent years, weight loss medications have gained significant attention, particularly as alternatives to established drugs like Ozempic and other GLP-1 receptor agonists. However, new research has ...

The conversation surrounding GLP-1 receptor agonist medications like Ozempic has taken a concerning turn, as recent discussions have emerged about a potential link to a rare form of vision loss known ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...